LOWELL, Mass. -- (BUSINESS WIRE) -- DiagnosisOne, an Alere subsidiary specializing in analytics and clinical decision support technology, today announced that the Company will now be conducting business as Alere Analytics. The name change reflects a continued focus on providing the healthcare industry with a broad array of analytical and clinical decision support solutions, including real-time patient and population assessment. These solutions are delivered through a powerful platform that integrates Meaningful Use-required interoperability and accountable-care standards at the point of care.
Alere Analytics, formally known as DiagnosisOne, embarked on a rebranding campaign after joining Alere in July 2012. The new name distinguishes the Company as an industry leader in providing intelligent, actionable information that comprehensively addresses gaps across the healthcare continuum.
“Like the other parts of Alere, we are dedicated to providing patient-centric solutions that improve health outcomes at the point of care and beyond,” said Mansoor Khan, Sc.D., Chief Executive Officer of Alere Analytics. “Analytics and decision support have become increasingly important to providers, hospitals and payers as they focus on empowering clinicians to make the most informed decisions and set accountable, value-driven care plans for their patients. Since our technology platform generates immediate care recommendations, our solution can trigger earlier interventions, reduce avoidable errors, and improve overall health outcomes at both a patient and population level.”
Commenting on the Alere Analytics rebranding, Alere Chief Executive Officer, Ron Zwanziger, stated, “Clinical decision support and analytics tools play a vital role in our ability to offer comprehensive health information solutions by enabling providers to personalize care for each patient, which in turn contributes to increased treatment effectiveness, improved outcomes, and reduced costs.”
Alere’s Clinical Decision Support solution leverages what is arguably the world’s largest library of evidence-based guidelines and activates patient information via patient-specific recommendations and alerts made at the point of care and in between doctor visits. Built to meet industry standards such as HL7v3, CCD and CDA, it can be easily integrated into any hospital HIS, EHR/PHR, and HIE system’s workflows. Its analytics tools, which facilitate population assessment, predictive modeling, and risk stratification, help providers improve care quality, lower costs, and maximize available incentive payments from programs that include HEDIS, PQRS, and Meaningful Use.
Key Features of the Alere Clinical Decision Support Solution:
Demonstrations can be seen at HIMSS13 booth #3060. To learn more about Alere’s overall health information solutions for value-driven care, visit the Alere Accountable Care Solutions booth #3129.
About Alere Analytics
Alere Analytics, formerly DiagnosisOne, provides the healthcare industry with unparalleled analytics and clinical decision support tools based on a single platform. The company’s analytics and decision support solution leverages the world's largest library of evidence-based medical knowledge and integrates seamlessly with existing hospital and laboratory information systems. It delivers intelligent and actionable information that ensures improved patient care, fewer errors and better clinical outcomes. Alere Analytics’ customers include hospitals, healthcare providers, payers, EHR companies, systems integrators and government entities. Based in Lowell, Mass., Alere Analytics was formed as DiagnosisOne in 2003 by a team of physicians and healthcare IT professionals. In July 2012, DiagnosisOne joined Alere, a leading provider of near-patient diagnostics and health information solutions, and is now conducting business as Alere Analytics. For more information about the Company and its solutions, visit www.DiagnosisOne.com.
About Alere Inc.
By developing new capabilities in near-patient diagnosis, monitoring and health information technology, Alere enables individuals to take charge of improving their health and quality of life at home. Alere's global leading products and services, as well as its new product development efforts, focus on cardiology, infectious disease, toxicology and diabetes. Alere is headquartered in Waltham, Massachusetts. For more information regarding Alere, please visit www.alere.com.